Related Experiment Videos
Calpain, a mediator of myelin breakdown in demyelinating diseases
D C Shields1, G E Deibler, N L Banik
1Department of Neurology, Medical University of South Carolina, Charleston 29425, USA.
Annals of the New York Academy of Sciences
|November 25, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Toll-like receptor 3 L412F polymorphism promotes a persistent clinical phenotype in pulmonary sarcoidosis.
QJM : monthly journal of the Association of Physicians·2017
Role of Calpain in Spinal Cord Injury: Effects of Calpain and Free Radical Inhibitorsa.
Annals of the New York Academy of Sciences·2017
G-protein beta3 subunit polymorphism and bleeding in the orbofiban in patients with unstable coronary syndromes-thrombolysis in myocardial infarction 16 trial.
Journal of thrombosis and haemostasis : JTH·2010
Infant Imitation and Rhythmic Movement in Response to Music and Speech.
Annals of the New York Academy of Sciences·2026
Female Budgerigars Attend Equally to Rhythmic Beat or Repetition, While Humans Prioritize Their Combination.
Annals of the New York Academy of Sciences·2026
A Theory of Planned Behavior-Based Cluster Randomized Trial to Improve Health Literacy Among Rural Adults in China.
Annals of the New York Academy of Sciences·2026
Pain Modulates Optimism-Biased Belief Updating and Confidence.
Annals of the New York Academy of Sciences·2026
FreqPolyp: Single-Source Domain Generalization for Polyp Segmentation via Amplitude Decoupling and Wavelet Cross-Attention.
Annals of the New York Academy of Sciences·2026
Atypical Inter-Brain Synchrony Network Couples With Behavioral and Linguistic Impairments in Autism Spectrum Disorder.
Annals of the New York Academy of Sciences·2026
Long-Term Efficacy and Allograft Loss after Immune Checkpoint Inhibitor Therapy in Solid Organ Transplant Recipients with Advanced Cutaneous Squamous Cell Carcinoma.
medRxiv : the preprint server for health sciences·2026
The therapy-conditioned host: a state-transition framework for second primary cancer evolution.
Frontiers in oncology·2026